CNTNAP2 and psychotic disorder: We tested serum from SLE psychosis patients for an array of antibodies directed against neuronal cell surface antigens that have been implicated as targets in psychosis (GABABR, DPPX, AMPAR1/2, NMDAR, LGI1, CASPR2) [14] in order to try and identify potential biomarkers.